Causes and treatment of oedema in patients with heart failure. (Q38074093): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older edit Newer edit →

Revision as of 03:49, 24 June 2020

scientific article published on 15 January 2013

Language	Label	Description	Also known as
English	Causes and treatment of oedema in patients with heart failure.	scientific article published on 15 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

Causes and treatment of oedema in patients with heart failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

0 references

author name string

Andrew L Clark

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

John G F Cleland

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

language of work or name

0 references

publication date

15 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Nature Reviews Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

156-170

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

https://scigraph.springernature.com/pub.10.1038/nrcardio.2012.191

0 references

The national heart failure audit for England and Wales 2008-2009.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

On the Absorption of Fluids from the Connective Tissue Spaces

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Acute dyspnoea resulting from pulmonary oedema as the first sign of a phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The value of edema fluid protein measurement in patients with pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Acute heart failure as "acute endothelitis"--Interaction of fluid overload and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Pulmonary edema develops after recurrent obstructive apneas

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Relationship between sodium intake and sleep apnea in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The role of pulmonary lymphatics in the clearance of hydrostatic pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Pulmonary vascular changes associated with isolated mitral stenosis in India

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Acute pulmonary oedema: clinical characteristics, prognostic factors, and in‐hospital management

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The unique role of diamorphine in British medical practice: a survey of general practitioners and hospital doctors

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Morphine-induced venodilation in humans

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Morphine-induced cardiogenic shock

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Continuous positive pressure ventilation in the management of eight cases of acute pulmonary oedema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Prehospital non-invasive ventilation for acute cardiogenic pulmonary oedema: an evidence-based review

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Noninvasive ventilation in acute cardiogenic pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Renal and Extrarenal Hemodynamic Effects of Furosemide in Congestive Heart Failure after Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The insufficient nitrate response: patients' characterization and response to beta and calcium blockade

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The Role of Furosemide in the Treatment of Left Ventricular Dysfunction Associated with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: a tissue Doppler study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Rapid improvement of acute pulmonary edema with sublingual captopril

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effect of nesiritide in patients with acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Lung epithelial fluid transport and the resolution of pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Alveolar epithelial beta2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Novel cardiac myosin activators for acute heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Tria

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Evolution and the cardiac patient

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Interactions between intrarenal epinephrine receptors and the renal baroreceptor in the control of PRA in conscious dogs.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Symptoms experienced in the last six months of life in patients with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Keeping the maintenance of daily life in spite of chronic heart failure. A qualitative study

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Thirst in the elderly with and without heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: a PET study.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The relationship between elevated water intake and oedema associated with congestive cardiac failure in the dog

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Thigh-Length Versus Below-Knee Stockings for Deep Venous Thrombosis Prophylaxis After Stroke

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Influence of progressive renal dysfunction in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Renal circulatory effects of adenosine in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Combination diuretic therapy in severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Pharmacology of diuretics

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Diuretic strategies in patients with acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Combination diuretic treatment in severe heart failure: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

DIGITALIS IN HEART FAILURE WITH NORMAL RHYTHM.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Early ultrafiltration in patients with decompensated heart failure and diuretic resistance

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Ultrafiltration in decompensated heart failure with cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Telemedicine and remote management of patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The atrial fibrillation paradox of heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

Identifiers

10.1038/NRCARDIO.2012.191

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38074093&oldid=1215217021"